GlassScriptPhysician profile
Raymond A Capone
NPI 1649377474
$1,352.32
in general payments reported to CMS, 2019-2025
11 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $179 · 2021: $164 · 2022: $107 · 2023: $111 · 2024: $173 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $464.54 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $280.00 | 2024-2025 | |
| Galderma Laboratories, L.P. | $240.15 | 2019 | |
| Mentor Worldwide LLC | $178.16 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $70.80 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Abbvie INC. | $34.40 | 2024 | |
| Axogen | $21.63 | 2022 | |
| Checkpoint Surgical, INC | $17.52 | 2022 | |
| Kerecis Limited | $17.32 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medline Industries LP | $14.08 | 2023 | |
| Biotissue Holdings INC. | $13.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Capone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.